These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6848397)

  • 1. Immunoreactive neurotensin in the pancreas of genetically obese and diabetic mice. A longitudinal study.
    Berelowitz M; Frohman LA
    Diabetes; 1983 Jan; 32(1):51-4. PubMed ID: 6848397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive neurotensin in spontaneous syndromes of obesity and diabetes in mice.
    Sheppard MC; Bailey CJ; Flatt PR; Swanston-Flatt SK; Shennan KI
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):532-6. PubMed ID: 3887830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice.
    Berelowitz M; Coleman DL; Frohman LA
    Diabetes; 1980 Sep; 29(9):717-23. PubMed ID: 6108273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered beta-endorphin, Met- and Leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome.
    Timmers K; Voyles NR; Zalenski C; Wilkins S; Recant L
    Diabetes; 1986 Oct; 35(10):1143-51. PubMed ID: 2944783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice.
    Bailey CJ; Flatt PR; Deacon CF; Shaw C; Conlon JM
    Regul Pept; 1986 Dec; 16(3-4):339-48. PubMed ID: 2436255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide content in pancreas and pituitary of obese and diabetes mutant mice: strain and sex differences.
    Timmers K; Coleman DL; Voyles NR; Powell AM; Rökaeus A; Recant L
    Metabolism; 1990 Apr; 39(4):378-83. PubMed ID: 1691431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive neurotensin levels in pancreas: elevation in diabetic rats and mice.
    Fernstrom MH; Mirski MA; Carraway RE; Leeman SE
    Metabolism; 1981 Sep; 30(9):853-5. PubMed ID: 6455583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet amyloid polypeptide/amylin contents in pancreata increase in genetically obese and diabetic mice.
    Tokuyama Y; Kanatsuka A; Yamaguchi T; Ohsawa H; Makino H; Nishimura M; Yoshida S
    Horm Metab Res; 1993 Jun; 25(6):289-91. PubMed ID: 8344641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in hepatic glycogen metabolism in the genetically diabetic (db/db) mouse.
    Roesler WJ; Khandelwal RL
    Diabetes; 1985 Apr; 34(4):395-402. PubMed ID: 2982686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice.
    Orland MJ; Permutt MA
    Diabetes; 1987 Mar; 36(3):341-7. PubMed ID: 3542656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neurotensin in the regulation of carbohydrate metabolism and in diabetes.
    Berelowitz M; Frohman LA
    Ann N Y Acad Sci; 1982; 400():150-9. PubMed ID: 6963110
    [No Abstract]   [Full Text] [Related]  

  • 15. A longitudinal and comparative study of some structural and hormonal alterations in the endocrine pancreas of spontaneously diabetic and streptozotocin-induced diabetic mice.
    Stearns SB; Benzo CA
    Acta Anat (Basel); 1983; 115(3):193-203. PubMed ID: 6221500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective regulation of Cl- permeability in islets of diabetic mice [C57BL/KsJ(db/db)].
    Berglund O; Sehlin J
    Diabetes; 1980 Feb; 29(2):151-5. PubMed ID: 6986301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive tract and pancreatic norepinephrine levels in pre- and overt-diabetic C57BL/KsJ mice: relationship to body weight, blood glucose, serum insulin, and reproductive dysfunction.
    Garris DR
    Proc Soc Exp Biol Med; 1988 Oct; 189(1):79-83. PubMed ID: 3054905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.
    Diani AR; Sawada G; Wyse B; Murray FT; Khan M
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E116-22. PubMed ID: 14532171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes is not associated with a change in the elemental composition of the pancreatic B cell in diabetic C57BL KsJ-db/db mice.
    Juntti-Berggren L; Lindh U; Berggren PO; Berglund O; Frankel BJ
    Biosci Rep; 1990 Apr; 10(2):217-23. PubMed ID: 2192765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.